Medical Laboratory Report

MR TUSHAR APL Code :APL-KA-371 Sample Type : SERUM

Age : 28 Year(s) Ref Doctor : SID : 10652085
Gender : Male Ref Cust : Collected on : 2026-02-07 00:00

Regd on : 2026-02-07 15:35

█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌
█▐
█▐
▌▐
▌▐
█▌▐▌▌▐█▐▌▐▌▐█▐
█▌▐▌▌▐█▐▌▐▌▐█▐
█▐█
█▐█
▌▐▌▐█
▌▐▌▐█
▌▌▐█▐▌▐█▐
▌▌▐█▐▌▐█▐
█
█
█▐█
█▐█
▌▐▌█
▌▐▌█
█
█
█
█
▐█▐▐▌
▐█▐▐▌ Reported on : 2026-02-07 19:20
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌

CLINICAL BIOCHEMISTRY
Test Description Result Units Biological Reference Ranges

Calcium 9.8 mg/dL 8.8 - 10.6

(Method: Spectrophotometry(Cresol Complex))

Folate Serum (Folic Acid) 7.2 ng/mL 0.35 - 3.37 : Deficient

(Method: Chemiluminescence)
3.38 - 5.38 : Indeterminate
> 5.9 : Normal
25-Hydroxy Vitamin D Total (D2 & D3) 28.52 ng/mL Deficient : <20
(Method: Chemiluminescence)
Insufficient : 20 to <30
Sufficient : 30-100
Upper Safety Limit : >100

Magnesium 2.1 mg/dL 1.8 - 2.6

(Method: Methyl thymol Blue)

Phosphorus 3.8 mg/dL 2.5 - 4.5

(Method: Spectrophotometry)

Dr [Link] DR. P PRASANNA B.K

Biochemist MD PATHOLOGIST

This is an electronically authenticated report. Report Printed Date : 07/02/2026 19:23

Page 1 of 11
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.
Processed at Acclin Pathlabs India Pvt Ltd BANGALORE Branch Report #
 Medical Laboratory Report

MR TUSHAR APL Code :APL-KA-371 Sample Type : SERUM

Age : 28 Year(s) Ref Doctor : SID : 10652085
Gender : Male Ref Cust : Collected on : 2026-02-07 00:00

Regd on : 2026-02-07 15:35

█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌
█▐
█▐
▌▐
▌▐
█▌▐▌▌▐█▐▌▐▌▐█▐
█▌▐▌▌▐█▐▌▐▌▐█▐
█▐█
█▐█
▌▐▌▐█
▌▐▌▐█
▌▌▐█▐▌▐█▐
▌▌▐█▐▌▐█▐
█
█
█▐█
█▐█
▌▐▌█
▌▐▌█
█
█
█
█
▐█▐▐▌
▐█▐▐▌ Reported on : 2026-02-07 19:20
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌

CLINICAL BIOCHEMISTRY
Test Description Result Units Biological Reference Ranges

Vitamin - B12 401 Pg/mL Deficiency : < 145

(Method: Chemiluminescence)
Indeterminate : 145 – 180
Normal : 180 - 914

eGFR-Creatinine clearance
Serum Creatinine 0.9 mg/dL 0.7 - 1.3
Blood Urea Nitrogen 11.5 mg/dL 6.0 - 20.0
Serum Albumin 5.0 g/dL 3.5 - 5.2
GFR by MDRD Formula 115.7 90 - 120 mL/min/1.73 m2

Dr [Link] DR. P PRASANNA B.K

Biochemist MD PATHOLOGIST

This is an electronically authenticated report. Report Printed Date : 07/02/2026 19:23

Page 2 of 11
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.
Processed at Acclin Pathlabs India Pvt Ltd BANGALORE Branch Report #
 Medical Laboratory Report

MR TUSHAR APL Code :APL-KA-371 Sample Type : SERUM

Age : 28 Year(s) Ref Doctor : SID : 10652085
Gender : Male Ref Cust : Collected on : 2026-02-07 00:00

Regd on : 2026-02-07 15:35

█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌
█▐
█▐
▌▐
▌▐
█▌▐▌▌▐█▐▌▐▌▐█▐
█▌▐▌▌▐█▐▌▐▌▐█▐
█▐█
█▐█
▌▐▌▐█
▌▐▌▐█
▌▌▐█▐▌▐█▐
▌▌▐█▐▌▐█▐
█
█
█▐█
█▐█
▌▐▌█
▌▐▌█
█
█
█
█
▐█▐▐▌
▐█▐▐▌ Reported on : 2026-02-07 19:20
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌

CLINICAL BIOCHEMISTRY
Test Description Result Units Biological Reference Ranges

LIPID PROFILE
Cholesterol - Total 147 mg/dL < 200 : Desirable
(Method: CHOD/PAP)
200-239 : Borderline risk
> 240 : High risk
Cholesterol - HDL 40 mg/dL < 40 : Low
(Method: Direct)
40 - 60 : Optimal
> 60 : Desirable
Cholesterol - LDL 63 mg/dL < 100 : Normal
(Method: Homogeneous enzymatic end point assay)
100 - 129 : Desirable
130 – 159 : Borderline-High
160 – 189 : High
> 190 : Very High
Cholesterol VLDL 43.8 mg/dL 7 - 40
(Method: Calculation)

Triglycerides 219 mg/dL < 150 : Normal

(Method: Lipase / Glycerol Kinase)
150–199 : Borderline-High
200–499 : High
> 500 : Very High
Total cholesterol/HDL ratio 3.7 Ratio 0 - 5.0
(Method: Calculation)

LDL / HDL Ratio 1.6 Ratio 0 - 3.5

(Method: Calculation)

Dr [Link] DR. P PRASANNA B.K

Biochemist MD PATHOLOGIST

This is an electronically authenticated report. Report Printed Date : 07/02/2026 19:23

Page 3 of 11
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.
Processed at Acclin Pathlabs India Pvt Ltd BANGALORE Branch Report #
 Medical Laboratory Report

MR TUSHAR APL Code :APL-KA-371 Sample Type : SERUM

Age : 28 Year(s) Ref Doctor : SID : 10652085
Gender : Male Ref Cust : Collected on : 2026-02-07 00:00

Regd on : 2026-02-07 15:35

█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌
█▐
█▐
▌▐
▌▐
█▌▐▌▌▐█▐▌▐▌▐█▐
█▌▐▌▌▐█▐▌▐▌▐█▐
█▐█
█▐█
▌▐▌▐█
▌▐▌▐█
▌▌▐█▐▌▐█▐
▌▌▐█▐▌▐█▐
█
█
█▐█
█▐█
▌▐▌█
▌▐▌█
█
█
█
█
▐█▐▐▌
▐█▐▐▌ Reported on : 2026-02-07 19:20
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌

CLINICAL BIOCHEMISTRY
Test Description Result Units Biological Reference Ranges

IRON PROFILE
Iron 163.9 µg/dL 59 - 158
(Method: Ferene)

Iron Binding Capacity - Total (TIBC) 285 µg/dL 240 - 450

(Method: Ferrozine)

Transferrin 193.9 µg/dL 176 - 280

(Method: Immunoturbidometry)

Transferrin % 57.5 % 20 - 50
(Method: Calculation)

Dr [Link] DR. P PRASANNA B.K

Biochemist MD PATHOLOGIST

This is an electronically authenticated report. Report Printed Date : 07/02/2026 19:23

Page 4 of 11
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.
Processed at Acclin Pathlabs India Pvt Ltd BANGALORE Branch Report #
 Medical Laboratory Report

MR TUSHAR APL Code :APL-KA-371 Sample Type : SERUM

Age : 28 Year(s) Ref Doctor : SID : 10652085
Gender : Male Ref Cust : Collected on : 2026-02-07 00:00

Regd on : 2026-02-07 15:35

█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌
█▐
█▐
▌▐
▌▐
█▌▐▌▌▐█▐▌▐▌▐█▐
█▌▐▌▌▐█▐▌▐▌▐█▐
█▐█
█▐█
▌▐▌▐█
▌▐▌▐█
▌▌▐█▐▌▐█▐
▌▌▐█▐▌▐█▐
█
█
█▐█
█▐█
▌▐▌█
▌▐▌█
█
█
█
█
▐█▐▐▌
▐█▐▐▌ Reported on : 2026-02-07 19:20
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌

CLINICAL BIOCHEMISTRY
Test Description Result Units Biological Reference Ranges

KIDNEY BASIC SCREEN

Creatinine(Serum) 0.9 mg/dL 0.7 - 1.3
(Method: Enzymatic)

Urea (Serum) 24.7 mg/dL 17 - 43

(Method: UV-Kinetic)

Blood Urea Nitrogen (BUN) 11.5 mg/dL 6.0 - 20.0

(Method: Calculation)

Blood Urea Nitrogen (BUN)/Creatinine 12.8 ratio 6 - 22

(Method: Calculation)

Sodium(Serum) 142 mmol/L 135 - 150

(Method: ISE Direct)

Potassium(Serum) 4.6 mmol/L 3.5 - 5.0

(Method: ISE Direct)

Chloride(Serum) 101 mmol/L 94 - 110

(Method: ISE Direct)

Uric Acid 8.9 mg/dL 3.5 - 7.2

(Method: Uricase)

Dr [Link] DR. P PRASANNA B.K

Biochemist MD PATHOLOGIST

This is an electronically authenticated report. Report Printed Date : 07/02/2026 19:23

Page 5 of 11
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.
Processed at Acclin Pathlabs India Pvt Ltd BANGALORE Branch Report #
 Medical Laboratory Report

MR TUSHAR APL Code :APL-KA-371 Sample Type : SERUM

Age : 28 Year(s) Ref Doctor : SID : 10652085
Gender : Male Ref Cust : Collected on : 2026-02-07 00:00

Regd on : 2026-02-07 15:35

█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌
█▐
█▐
▌▐
▌▐
█▌▐▌▌▐█▐▌▐▌▐█▐
█▌▐▌▌▐█▐▌▐▌▐█▐
█▐█
█▐█
▌▐▌▐█
▌▐▌▐█
▌▌▐█▐▌▐█▐
▌▌▐█▐▌▐█▐
█
█
█▐█
█▐█
▌▐▌█
▌▐▌█
█
█
█
█
▐█▐▐▌
▐█▐▐▌ Reported on : 2026-02-07 19:20
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌

CLINICAL BIOCHEMISTRY
Test Description Result Units Biological Reference Ranges

LIVER FUNCTION PROFILE

Bilirubin Total 2.8 mg/dL 0.3 - 1.2
(Method: Diazotised Sulphanilic Acid)

Bilirubin Direct 0.6 mg/dL < 0.2

(Method: Diazotised Sulphanilic Acid)

Bilirubin Indirect 2.2 mg/dL 0 - 1.0

(Method: Calculation)

Alkaline Phosphatase (ALP) 59 U/L 43 -115

(Method: AMP Buffer)

Alanine Transaminase (ALT/SGPT) 67 U/L < 50

(Method: UV with pyridoxal - 5 - phosphate)

Aspartate Aminotransferase(AST/SGOT) 46 U/L < 50

(Method: UV with Pyridoxal-5-phosphate)

Y- Glutamyl Transferase (GGT) 32 U/L < 55

(Method: g-Glut-3-carboxy-4 nitro)

Protein Total 7.6 g/dL 6.6 - 8.3

(Method: BIURET)

Albumin 5.0 g/dL 3.5 - 5.2

(Method: Bromocresol Purple)

Globulin 2.6 g/dL 2.5 - 3.5

(Method: Calculated)

Albumin / Globulin Ratio 1.9 ratio 1.0 - 2.1

(Method: Calculation)

Dr [Link] DR. P PRASANNA B.K

Biochemist MD PATHOLOGIST

This is an electronically authenticated report. Report Printed Date : 07/02/2026 19:23

Page 6 of 11
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.
Processed at Acclin Pathlabs India Pvt Ltd BANGALORE Branch Report #
 Medical Laboratory Report

MR TUSHAR APL Code :APL-KA-371 Sample Type : SERUM

Age : 28 Year(s) Ref Doctor : SID : 10652085
Gender : Male Ref Cust : Collected on : 2026-02-07 00:00

Regd on : 2026-02-07 15:35

█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌
█▐
█▐
▌▐
▌▐
█▌▐▌▌▐█▐▌▐▌▐█▐
█▌▐▌▌▐█▐▌▐▌▐█▐
█▐█
█▐█
▌▐▌▐█
▌▐▌▐█
▌▌▐█▐▌▐█▐
▌▌▐█▐▌▐█▐
█
█
█▐█
█▐█
▌▐▌█
▌▐▌█
█
█
█
█
▐█▐▐▌
▐█▐▐▌ Reported on : 2026-02-07 19:20
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌

CLINICAL BIOCHEMISTRY
Test Description Result Units Biological Reference Ranges

THYROID PANEL II
TriIodothyronine Total (TT3) 141.5 ng/dL 80 - 253 : 1 Yr-10 Yr,
(Method: Chemiluminescence)
76 - 199 : 11 Yr-15 Yr,
69 - 201 : 16 Yr-18 Yr,
87 - 178 : > 18 years.
TriIodothyronine Free (FT3) 2.88 pg/mL 2.5 - 3.9
(Method: Chemiluminescence)

Thyroxine - Total (TT4) 8.52 µg/dL 6.09 - 12.23

(Method: Chemiluminescence)

Thyroxine - Free (FT4) 0.79 ng/dL 0.61 - 1.12

(Method: Chemiluminescence)

Thyroid Stimulating Hormone (TSH) 3.51 µIU/mL 0.52-16.0 : 1 Day - 30 Days

(Method: Ultra-sensitive chemiluminescence)
0.55-7.10 : 1 Mon-5 Years
0.37-6.00 : 6 Yrs-18 Years
0.38-5.33 : 18 Yrs-88 Years
0.50-8.90 : > 88 Years

Dr [Link] DR. P PRASANNA B.K

Biochemist MD PATHOLOGIST

This is an electronically authenticated report. Report Printed Date : 07/02/2026 19:23

Page 7 of 11
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.
Processed at Acclin Pathlabs India Pvt Ltd BANGALORE Branch Report #
 Medical Laboratory Report

MR TUSHAR APL Code :APL-KA-371 Sample Type : WB EDTA

Age : 28 Year(s) Ref Doctor : SID : 10652084
Gender : Male Ref Cust : Collected on : 2026-02-07 00:00

Regd on : 2026-02-07 15:15

█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █ ▌▐█▐▐█▌▌ █ ▐█▐▐▌
█▐
█▐
▌▐
▌▐
█▌▐▌▌▐█▐▌▐▌▐█▐
█▌▐▌▌▐█▐▌▐▌▐█▐
█▐█
█▐█
▌▐▌▐█
▌▐▌▐█
▌▌▐█▐▌▐█▐
▌▌▐█▐▌▐█▐
█
█
█
█
▌▐█▐▐█▌▌
▌▐█▐▐█▌▌
█
█
▐█▐▐▌
▐█▐▐▌ Reported on : 2026-02-07 18:35
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █ ▌▐█▐▐█▌▌ █ ▐█▐▐▌
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █ ▌▐█▐▐█▌▌ █ ▐█▐▐▌
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █ ▌▐█▐▐█▌▌ █ ▐█▐▐▌

CLINICAL BIOCHEMISTRY
Test Description Result Units Biological Reference Ranges

GLYCOSYLATED HEMOGLOBIN ( HbA1c )

(Method: ion-exchange high-performance liquid chromatography(HPLC))

Hemoglobin A1c (HbA1c) 5.9 % < 6 : Non Diabetic

6-7 : Good Control
7-8 : Poor Control
> 8 : Alert
Estimated average glucose (eAG) 122.63 % HbA1c(%) : eAG(mg/dL)
6 : 125
6.5 : 140
7 : 154
7.5 : 169
8 : 183
8.5 : 197
9 : 212
9.5 : 226
10 : 240

Dr [Link] DR. P PRASANNA B.K

Biochemist MD PATHOLOGIST

This is an electronically authenticated report. Report Printed Date : 07/02/2026 19:23

Page 8 of 11
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.
Processed at Acclin Pathlabs India Pvt Ltd BANGALORE Branch Report #
 Medical Laboratory Report

MR TUSHAR APL Code :APL-KA-371 Sample Type : WB EDTA

Age : 28 Year(s) Ref Doctor : SID : 10652084
Gender : Male Ref Cust : Collected on : 2026-02-07 00:00

Regd on : 2026-02-07 15:15

█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █ ▌▐█▐▐█▌▌ █ ▐█▐▐▌
█▐
█▐
▌▐
▌▐
█▌▐▌▌▐█▐▌▐▌▐█▐
█▌▐▌▌▐█▐▌▐▌▐█▐
█▐█
█▐█
▌▐▌▐█
▌▐▌▐█
▌▌▐█▐▌▐█▐
▌▌▐█▐▌▐█▐
█
█
█
█
▌▐█▐▐█▌▌
▌▐█▐▐█▌▌
█
█
▐█▐▐▌
▐█▐▐▌ Reported on : 2026-02-07 18:35
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █ ▌▐█▐▐█▌▌ █ ▐█▐▐▌
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █ ▌▐█▐▐█▌▌ █ ▐█▐▐▌
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █ ▌▐█▐▐█▌▌ █ ▐█▐▐▌

HAEMATOLOGY
Test Description Result Units Biological Reference Ranges

Erythrocyte Sedimentation Rate (ESR) 20 mm/Hour <10

(Method: Westergren's method)

G MANIRATNAM DR. P PRASANNA B.K

Group Leader MD PATHOLOGIST

This is an electronically authenticated report. Report Printed Date : 07/02/2026 19:23

Page 9 of 11
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.
Processed at Acclin Pathlabs India Pvt Ltd BANGALORE Branch Report #
 Medical Laboratory Report

MR TUSHAR APL Code :APL-KA-371 Sample Type : WB EDTA

Age : 28 Year(s) Ref Doctor : SID : 10652084
Gender : Male Ref Cust : Collected on : 2026-02-07 00:00

Regd on : 2026-02-07 15:15

█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █ ▌▐█▐▐█▌▌ █ ▐█▐▐▌
█▐
█▐
▌▐
▌▐
█▌▐▌▌▐█▐▌▐▌▐█▐
█▌▐▌▌▐█▐▌▐▌▐█▐
█▐█
█▐█
▌▐▌▐█
▌▐▌▐█
▌▌▐█▐▌▐█▐
▌▌▐█▐▌▐█▐
█
█
█
█
▌▐█▐▐█▌▌
▌▐█▐▐█▌▌
█
█
▐█▐▐▌
▐█▐▐▌ Reported on : 2026-02-07 18:35
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █ ▌▐█▐▐█▌▌ █ ▐█▐▐▌
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █ ▌▐█▐▐█▌▌ █ ▐█▐▐▌
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █ ▌▐█▐▐█▌▌ █ ▐█▐▐▌

HAEMATOLOGY
Test Description Result Units Biological Reference Ranges

COMPLETE BLOOD PICTURE

Hemoglobin 12.2 g/dL 13.0 - 18.0
(Method: Spectrophotometry)

Erythrocyte Count (RBC Count) 6.68 mil/µL 4.5 - 5.5

(Method: Impedance)

Packed Cell Volume(Hematocrit) 38.6 % 40 - 54

(Method: Calculated)

Platelet Count 1.25 lakh/Cumm 1.50 - 4.50

(Method: Impedance/ Microscopy)

Red Cell Indices

(Method: Automated 5 part Cell counter/ Calculated)

MCV 58 fl 83 - 101
MCH 18.3 pg 27 - 32
MCHC 31.6 g/dL 31.5 - 34.5
RDW-CV 16.9 % 11.5 - 14.5
Total Count and Differential Count
(Method: Impedance/Microscopy)

Total Leucocyte Count(WBC) 8900 cells/Cumm 4000 - 11000

Neutrophils 50 % 40 - 75
Lymphocytes 46 % 20 - 40
Eosinophils 02 % 0-6
Monocytes 02 % 2 - 10
Basophils 00 % 0-1
Microscopic Blood Picture
(Method: Microscopy)

RBC Morphology Microcytic Hyphochromic cells

WBC Morphology Relative Lymphocytosis
Platelet Morphology Thrombocytopenia
Hemoparasites Not found
Impression Microcytic Hyphochromic Blood Picture with Relative
Lymphocytosis,Thrombocytopenia
Advise Correlate Clinically

G MANIRATNAM DR. P PRASANNA B.K

Group Leader MD PATHOLOGIST

This is an electronically authenticated report. Report Printed Date : 07/02/2026 19:23

Page 10 of 11
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.
Processed at Acclin Pathlabs India Pvt Ltd BANGALORE Branch Report #
 Medical Laboratory Report

MR TUSHAR APL Code :APL-KA-371 Sample Type : SERUM

Age : 28 Year(s) Ref Doctor : SID : 10652085
Gender : Male Ref Cust : Collected on : 2026-02-07 00:00

Regd on : 2026-02-07 15:35

█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌
█▐
█▐
▌▐
▌▐
█▌▐▌▌▐█▐▌▐▌▐█▐
█▌▐▌▌▐█▐▌▐▌▐█▐
█▐█
█▐█
▌▐▌▐█
▌▐▌▐█
▌▌▐█▐▌▐█▐
▌▌▐█▐▌▐█▐
█
█
█▐█
█▐█
▌▐▌█
▌▐▌█
█
█
█
█
▐█▐▐▌
▐█▐▐▌ Reported on : 2026-02-07 19:20
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌
█▐ ▌▐ █▌▐▌▌▐█▐▌▐▌▐█▐ █▐█ ▌▐▌▐█ ▌▌▐█▐▌▐█▐ █ █▐█ ▌▐▌█ █ █ ▐█▐▐▌

IMMUNOLOGY/SEROLOGY
Test Description Result Units Biological Reference Ranges

Widal Test (Slide Test)

(Method: Agglutination)

Salmonella typhi O" Antigen" 1:40(Negative) 1:80 & Above Significant

Salmonella typhi H" Antigen" 1:40(Negative) 1:80 & Above Significant
Salmonella typhi AH" Antigen" <1:20(Negative) 1:80 & Above Significant
Salmonella typhi BH" Antigen" <1:20(Negative) 1:80 & Above Significant

[Link] [Link]
Manager Technical MD MICROBIOLOGIST

This is an electronically authenticated report. Report Printed Date : 07/02/2026 19:23

Page 11 of 11
NOTE : Assay results should be correlated clinically with other clinical findings and the total clinical status of the patient.
Processed at Acclin Pathlabs India Pvt Ltd BANGALORE Branch Report #